Incidence of Venous Thromboembolism and Professional Practices in Brest Area
NCT ID: NCT02895971
Last Updated: 2017-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1416 participants
OBSERVATIONAL
2013-03-04
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Six Years of Follow-up After Idiopathic Venous Throbmoembolism
NCT02884934
Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence
NCT04297085
Cohort for Monitoring Patients With Venous Thromboembolic Disease
NCT07016542
Incidence and Outcomes of Venous Thromboembolism
NCT00005351
Prevention of Venous Thromboembolism Disease in Emergency Departments
NCT01212393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient living in Brest area from time of diagnosis
Exclusion Criteria
* asymptomatic event
* Main residence patient out of Brest area.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Brest
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EPIGETBO III (RB 12.157)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.